Here's the latest info on pharmaceutical treatments and vaccines:
The COVID-19 coronavirus pandemic poses a unique challenge for healthcare providers. There are no approved treatments for this disease, nor are there any approved vaccines.
That’s put big drug companies, universities and biotech startups on the hot seat. Since the 2003 outbreak of SARS, another variety of deadly coronavirus, they’ve been researching ways to handle diseases that can be produced by this family of viruses. When a coronavirus is capable of infecting humans, it typically attacks the respiratory system, which can make them particularly deadly.
It usually takes about 10 to 15 years to develop a vaccine. The good news: leaps in technology, such as the ability to rapidly sequence virus genomes and to create vaccines out of messenger RNA, are speeding up the process of development. Developing new drug treatments can also take time—about a decade from discovery to getting on the market. But here technology also provides an advantage. New types of antiviral drugs and immunotherapy treatments can treat a wide range of diseases.
On this page, we’ll be tracking and regularly updating the development of new treatments and vaccines for COVID-19, from research to testing to commercial release.... [+]For the past few years, Foster City, California-based Gilead has been developing Remdesivir, an anti-viral that’s shown promising results in lab and animal studies against SARS, MERS, Ebola and other infectious diseases, including COVID-19.
in the U.S. and China to see if the drug can be effective against the new coronavirus, and also working with governments to provide the drug as an emergency treatment in the absence of other options.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Liam Hemsworth, Clark Duke Take on Vince Vaughn's Drug Dealer Boss in 'Arkansas' TrailerLiam Hemsworth and Clark Duke retaliate against their drug dealer boss in the trailer for Lionsgate's 'Arkansas.' Watch the trailer:
続きを読む »
Stock market live updates: Stocks rebound, Dow up 300, Regeneron speeds up drugStock market live updates: Stocks attempted a rebound from the worst day since 1987, with all 3 major averages opening in positive territory.
続きを読む »
Pharmacogenomics can show what your body makes of a drugPharmacogenetics is the study of how genes affect an individual’s response to drugs. It is an area of science that is flourishing
続きを読む »
Coronavirus vaccine trial starts Monday, government official saysA clinical trial evaluating a vaccine designed to protect against the new coronavirus will begin Monday.
続きを読む »
AP Exclusive: Coronavirus vaccine test opens with 1st dosesU.S. researchers gave the first shots in first test of experimental coronavirus vaccine Monday, leading off worldwide hunt for protection as pandemic surges.
続きを読む »